These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3431335)

  • 1. Contribution of relapses to total infection sources of leprosy in Guadeloupe.
    Cartel JL; Naudillon Y; Remy JC; Grosset JH
    Lepr Rev; 1987 Dec; 58(4):339-48. PubMed ID: 3431335
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leprosy in Guadeloupe].
    Floch HA
    Bull Soc Pathol Exot Filiales; 1972; 65(1):35-46. PubMed ID: 4677872
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiology of leprosy in Guadeloupe from 1970 to 1984].
    Cartel JL; Gallais JJ; Naudillon Y; Rémy JG; Grosset JH
    Acta Leprol; 1986; 4(2):161-73. PubMed ID: 3551448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiology of leprosy in Guadalupe between 1970 and 1983].
    Cartel JL; Naudillon Y; Artus JC; Grosset JH
    Bol Oficina Sanit Panam; 1985 Jun; 98(6):535-47. PubMed ID: 3160362
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leprosy in Guadeloupe 1980-1990: development and management in the general hospital].
    Strobel M; Gros de Beler A; Arnaud JP; Sibille G
    Bull Soc Pathol Exot; 1992; 85(1):22-5. PubMed ID: 1596953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
    Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
    Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy.
    Jesudasan K; Christian M
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):19-21. PubMed ID: 3998560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
    Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate and time distribution of relapses in multibacillary leprosy.
    Kurz XM; Declercq EE; Vellut CM
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):599-606. PubMed ID: 2778367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
    Cartel JL; Gallais JJ; Grosset JH
    Acta Leprol; 1985; 3(4):339-55. PubMed ID: 3913270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The evolution and current epidemiological status of leprosy in Guadeloupe: analysis of data from the Department's central files].
    Millan J; Feral J; Rostant M; Lecorroller Y; Pilachon S; Naudillon Y; Diman C
    Acta Leprol; 1979; (76-77):73-88. PubMed ID: 121861
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of leprosy and immunologic considerations.
    Chatterjee BR
    Lepr India; 1981 Apr; 53(2):142-51. PubMed ID: 7253567
    [No Abstract]   [Full Text] [Related]  

  • 15. Leprosy in the Americas region (AMRO).
    Motta CP
    Lepr Rev; 1980 Dec; 51(4):285-94. PubMed ID: 7219014
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapses in multibacillary leprosy.
    Reddy RN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):379-80. PubMed ID: 2376684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Survey on the prevalence rate of dapsone-resistant leprosy in the Yangzhou district].
    Li WZ; Ye GY; Wang HY; Tao MB; Ma B; Zhang YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):59-61. PubMed ID: 6238701
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of leprosy and response to treatment in Hong Kong.
    Ho CK; Lo KK
    Hong Kong Med J; 2006 Jun; 12(3):174-9. PubMed ID: 16760543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy undefeated.
    Browne SG
    Lancet; 1965 Sep; 2(7412):582-3. PubMed ID: 4158202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of 6 years of leprosy screening in a sector of Guadeloupe].
    Millan J; Lecoeur H
    Acta Leprol; 1979; (76-77):99-106. PubMed ID: 121864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.